ATLANYS Trademark
Trademark Overview
On Monday, August 10, 2015, a trademark application was filed for ATLANYS with the United States Patent and Trademark Office. The USPTO has given the ATLANYS trademark a serial number of 79172945. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, November 15, 2024. This trademark is owned by NOVARTIS AG. The ATLANYS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
General Information
| Serial Number | 79172945 |
| Word Mark | ATLANYS |
| Filing Date | Monday, August 10, 2015 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Friday, November 15, 2024 |
| Registration Number | 4894053 |
| Registration Date | Tuesday, February 2, 2016 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 17, 2015 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | H - NOT AVAILABLE |
| Class Status Date | Tuesday, December 18, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | NOVARTIS AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Thursday, September 24, 2015 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, September 25, 2015 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Monday, September 28, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, October 5, 2015 | ASSIGNED TO EXAMINER |
| Friday, October 2, 2015 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, October 28, 2015 | NOTICE OF PUBLICATION |
| Wednesday, November 4, 2015 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, November 4, 2015 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, February 2, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Saturday, March 5, 2016 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, March 25, 2016 | NOTIFICATION PROCESSED BY IB |
| Friday, January 4, 2019 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, January 4, 2019 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Friday, November 1, 2019 | NOTIFICATION PROCESSED BY IB |
| Monday, December 2, 2024 | DEATH OF INTERNATIONAL REGISTRATION |
| Saturday, March 5, 2016 | FINAL DISPOSITION PROCESSED |
| Tuesday, October 6, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, November 17, 2015 | PUBLISHED FOR OPPOSITION |
| Friday, November 20, 2015 | NOTIFICATION PROCESSED BY IB |
| Thursday, March 3, 2016 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
